Suave 24-Hour Protection Aerosol Antiperspirant Recalled Nationwide for Benzene Contamination
Suave 24-Hour Protection Aerosol Antiperspirant has been recalled nationwide due to the presence of benzene. The recall affects 4 oz. and 6 oz. cans bearing expiration date 9/30/2023.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA classified this recall as Class I, the most serious type of FDA drug recall, which is explicitly listed as a criterion for the highest severity score per the rubric.
Plain-English summary
Suave 24-Hour Protection Aerosol Antiperspirant Powder scent, manufactured by Unilever United States Inc., has been recalled. The product contains Aluminum Chlorohydrate (19.1%) as the active ingredient. The recall affects two package sizes: 4 oz. cans (UPC 0 79400 75150 8) and 6 oz. cans (UPC 0 79400 78490 2).
The FDA initiated this Class I recall because the product was found to contain benzene, a chemical contaminant. All lots of the product with an expiration date of 9/30/2023 are included in this recall.
The affected product was distributed nationwide in the United States. This recall was issued under FDA recall number D-0210-2024.
The recalled product
- Product
- Suave 24-Hour Protection Aerosol Antiperspirant Powder scent, Aluminum Chlorohydrate (19.1%), packaged in a) 4 oz. cans (UPC 0 79400 75150 8), and b) 6 oz. cans (UPC 0 79400 78490 2), Dist. By Unilever, Trumbull, CT 06611
- Manufacturer
- Unilever United States Inc.
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- all lots
- expiry 9/30/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateFentanyl Citrate Sterile Injection Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27